Keywords: Drug tariffs, prescription drugs, healthcare costs, Trump administration, pharmaceutical industry, consumer impact, U.S. manufacturing, patient access, medication prices, healthcare policy

Episode Description:This conversation delves into the new tariffs on prescription drugs announced by President Trump, which could significantly impact consumers, particularly senior citizens. The discussion highlights the potential doubling of costs for certain medications manufactured outside the U.S. and the implications for healthcare access and affordability. The urgency of the situation is emphasized, as these changes take effect October 1 , raising concerns about the financial burden on patients and the timeline for domestic manufacturing solution